0000899243-23-008013.txt : 20230310 0000899243-23-008013.hdr.sgml : 20230310 20230310161101 ACCESSION NUMBER: 0000899243-23-008013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230309 FILED AS OF DATE: 20230310 DATE AS OF CHANGE: 20230310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIMPSON TODD E CENTRAL INDEX KEY: 0001216477 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 23723716 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-09 0 0001060736 Seagen Inc. SGEN 0001216477 SIMPSON TODD E 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 Chief Financial Officer Common Stock 2023-03-09 4 M 0 42793 45.30 A 159978 D Common Stock 2023-03-09 4 S 0 10262 175.89 D 149716 D Common Stock 2023-03-09 4 S 0 26449 176.71 D 123267 D Common Stock 2023-03-09 4 S 0 6082 177.37 D 117185 D Non-Qualified Stock Option (right to buy) 45.30 2023-03-09 4 M 0 42793 0.00 D 2026-08-27 Common Stock 42793 0 D Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Reflects sales of common stock executed in multiple transactions at prices ranging from $175.19 to $176.18. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $176.19 to $177.19. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $177.19 to $177.59. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Options vested at a rate of 25% on 8/27/17 and monthly thereafter until all the options were fully vested on 8/27/20. By: /s/ Jennifer Prosba For: Todd Simpson 2023-03-10